LuSeed Vascular

Vascular Remodeling Device

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in October 2017 by Nitzan Hirsh and Amir Arthur, LuSeed Vascular operates with 11–50 employees. The company has raised $6.5 million across three funding rounds from four investors. In October 2024, Sanara Capital participated in a funding round, underscoring continued investor interest in.

Business overview

LuSeed Vascular is a medical technology startup focused on advancing neurovascular innovation. The company develops the LuSeed ARC, a first-in-class, minimally invasive device designed for treating both Bifurcation and Sidewall brain aneurysms. This technology aims to provide a standard method of care that is easily implemented by neuro radiologists, improving patient outcomes, mitigating complications, and optimizing hospital operations. LuSeed Vascular operates within the Health Tech & Life Sciences sector, specifically targeting the medical devices industry with its therapeutic devices and implants, serving healthcare providers in North America, Asia, and Europe.

Strategic signal

In December 2022, LuSeed Vascular appointed Robert Stern to its board of directors. This strategic addition of an experienced professional to the leadership team signals a strengthening of governance and expertise, which is crucial for navigating clinical phases and market expansion in the highly regulated medical technology sector. For investors, this indicates a commitment to robust leadership as the company progresses with its neurovascular innovation.

Log in to access full profile

Company Intelligence Q&A

What is LuSeed Vascular's core product?
LuSeed Vascular's core product is the LuSeed ARC, a minimally invasive device designed for treating Bifurcation and Sidewall brain aneurysms. It is intended for full compatibility with robotic systems.
When was LuSeed Vascular founded and by whom?
LuSeed Vascular was founded in October 2017 by Nitzan Hirsh and Amir Arthur.
What was a significant recent development for LuSeed Vascular?
In October 2024, Sanara Capital participated in a funding round for.
Who joined LuSeed Vascular's board of directors?
In December 2022, LuSeed Vascular appointed Robert Stern to its board of directors.
Which investors participated in LuSeed Vascular's January 2020 funding round?
In January 2020, Sanara Ventures led a funding round for.
Log in to access full profile